TickerFactsScreenerDevelopers

SUPERNUS PHARMACEUTICALS, INC. (SUPN) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2011: $44.29M2012: $36.42M2013: $77.53M2014: $96.08M2015: $100.62M2016: $117.81M2017: $156.98M2018: $524.79M2019: $564.85M2020: $759.24M2021: $873.30M2022: $816.30M2023: $356.16M2024: $332.34M2025: $390.93M$390.93M
2011Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$390.93M+17.6%
2024$332.34M-6.7%
2023$356.16M-56.4%
2022$816.30M-6.5%
2021$873.30M+15.0%
2020$759.24M+34.4%
2019$564.85M+7.6%
2018$524.79M+234.3%
2017$156.98M+33.2%
2016$117.81M+17.1%
2015$100.62M+4.7%
2014$96.08M+23.9%
2013$77.53M+112.9%
2012$36.42M-17.8%
2011$44.29M—